纤溶酶原激活物抑制剂-1基因多态性与冠心病的关系
Relationship between the gene polymorphism of plasminogen activator inhibitor-1 and coronary heart disease
出处
《华北煤炭医学院学报》
2007年第2期172-174,共3页
Journal of North China Coal Medical College
参考文献22
-
1[1]Henry M,Tregouet DA,Alessi MC,et al.Metabolic deteminants are much more important than genetic polymorphisms in determining the PAI-1 activity and antigen plasma concentrations:a family study with part of the Stanislas Cohort[J].Arterioscler Thromb Vasc Biol,1998,18 184
-
2[2]Dawson S,Hamsten A,Wiman B,et al.Genetic variation at the plasminogen activator inhibitor-1 locus is associated with altered levels of plasma plasminogen activator inhibitor-1 activity[J].Arterioscler Thromb.1991,11:183
-
3[3]Zalewski A,Shi Y,Nardone D,et al.Evidence for reduced fibrinolytic activity in unstable angina at rest:clinical biochemical and angiographic correlates[J].Circulation,1991,83:1685
-
4[4]Robbie LA,Booth NA,Brown PAJ,et al.Inhibitors of fibrinolysis are elevated in atherosclerotic plaque[J].Arterioscler Thromb Vasc Biol,1996.89:6998
-
5[5]Kimura H,Gejyo F,Suzuki Y,et al.Polymorphisms of angiotensin coverting enzyme and plasminogen activator inhibitor-1 gene in diabetes and macroangiopathy[J].Kidney Int,1998,54:1659
-
6[6]Mansfield MW,Stickland MH,Grant PJ.Environmental and genetic factors in relation to elevated circulating levels of plasminogen activator inhibitor-1 in Caucasian patients with non-insulin-dependent diabetes mellitus[J].Thromb Haemost,1995.74:842
-
7[7]McCormack LJ,Nagi DK,Stickland MH,et al.Promoter(4G/5G)plasmi-nogen activator inhibitor-1 genotype in Pima Indians:relationship to plasminogen activator inhibitor-1 levels and feature of the insulin resistance syndrome[J].Diabetologia,1996,39:1512
-
8[8]Kain K,Young J,Bamford J,et al.Determinants of plasminogen activator inhibitor-1 in South Asians with ischaemic stroke[J].Cerebro-vasc Dis,2002,2:77
-
9[9]Rizzo MR,Ragno E,Barbieri M,et al.Elevated plasma activator inhibitor-1 is not related to insulin resistance and to gene polymorphism in healthy centenarians[J].Atherosclerosis,2002,160:385
-
10[10]Hoffstedt J,Andersson IL,Persson L,et al.The common-675 4G/5G polymorphism in the plasminogen activator inhibitor-1 gene is strongly associated with obesity[J].Diabetologia,2002,45:584
-
1老年高血压患者心房颤动急性发作后血栓前状态的改变[J].中华高血压杂志,2009,17(5):480-480.
-
2林凡峰,林凡源,张效艳.银杏叶片联合阿托伐他汀对高脂血症患者血脂及纤溶系统的影响研究[J].临床合理用药杂志,2011,4(05X):25-26. 被引量：3
-
3肖立中,高凌俊.氯沙坦对高血压病患者尿白蛋白及纤溶活性的影响[J].岭南心血管病杂志,2001,7(4):243-245.
-
4傅研,王旭东,翟艳苓,朱宇清,王瑾,赵相印.老年冠心病患者纤溶酶原激活抑制剂的变化[J].中华老年医学杂志,2001,20(3):189-190. 被引量：3
-
5阳新洪.影响冠心病发病的危险因素评价分析[J].中国现代药物应用,2015,9(10):84-85. 被引量：3
-
6郭松佳,李元宏.128例冠心病患者危险因素研究[J].长治医学院学报,2011,25(5):343-346. 被引量：5
-
7于涛,张文杰,王宝印,许月丹,毕展建.藻酸双酯钠对心绞痛病人血浆t-PA/PAI-1的影响及其疗效观察[J].中西医结合心脑血管病杂志,2005,3(11):950-951. 被引量：2
-
8杨春花,黄烽.类风湿关节炎患者滑膜、滑液和血浆中PAI的检测及其临床意义[J].中华内科杂志,2000,39(10):690-693. 被引量：3
-
9徐先明.妊娠期亚临床甲状腺功能减退症的筛查[J].中华围产医学杂志,2012,15(2):73-75. 被引量：9
-
10钟银燕,包斐丰.阿托伐他汀联合银杏叶片对高脂血症患者血脂代谢和纤溶系统的影响[J].中国现代医生,2011,49(6):46-47. 被引量：4
